Back
Vincerx Pharma Vs. Protalix BioTherapeutics Industry Stock Comparison
Sell
14
VINC
Vincerx Pharma
Last Price:
0.34
Seasonality Move:
3.02%
Buy
64
PLX
Protalix BioTherapeutics
Last Price:
1.17
Seasonality Move:
66.95%
Sell
14
Vincerx Pharma (VINC)
is a Sell
Is Vincerx Pharma a Buy, Sell or Hold?
- The current Vincerx Pharma [VINC] share price is $0.35. The Score for VINC is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- VINC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
64
Protalix BioTherapeutics (PLX)
is a Buy
Is Protalix BioTherapeutics a Buy, Sell or Hold?
- The current Protalix BioTherapeutics [PLX] share price is $1.17. The Score for PLX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- PLX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VINC Stock Price Chart
What is Vincerx Pharma's stock price today?
-
The Vincerx Pharma share price today is $0.35
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VINC is experiencing slight selling pressure.
PLX Stock Price Chart
What is Protalix BioTherapeutics's stock price today?
-
The Protalix BioTherapeutics share price today is $1.17
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing selling pressure, which indicates risk of future bearish movement.
VINC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 27.98 | Sell |
| Chaikin Money Flow: | -32452 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.35 - 0.65) | Sell |
| Bollinger Bands (100): | (0.51 - 0.77) | Sell |
PLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 64.48 | Buy |
| Chaikin Money Flow: | -135007 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.01 - 1.11) | Buy |
| Bollinger Bands (100): | (0.99 - 1.15) | Buy |
VINC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.37 | Sell |
| 20-day SMA: | 0.45 | Sell |
| 50-day SMA: | 0.62 | Sell |
| 200-day SMA: | 1.57 | Sell |
| 8-day EMA: | 0.38 | Sell |
| 20-day EMA: | 0.44 | Sell |
| 50-day EMA: | 0.56 | Sell |
| 200-day EMA: | 1.07 | Sell |
PLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.09 | Buy |
| 20-day SMA: | 1.06 | Buy |
| 50-day SMA: | 1.04 | Buy |
| 200-day SMA: | 1.2 | Sell |
| 8-day EMA: | 1.11 | Buy |
| 20-day EMA: | 1.08 | Buy |
| 50-day EMA: | 1.06 | Buy |
| 200-day EMA: | 1.2 | Sell |
Vincerx Pharma Earnings Growth & VINC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.05 per share, and a decrease next year of $0.02 per share.
Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Vincerx Pharma Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Protalix BioTherapeutics Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||